Erlotinib Hydrochloride 46708-0567-90
- Manufacturer
- Alembic Pharmaceuticals Limited
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 9, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA214719
Need to source Erlotinib Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Erlotinib Hydrochloride | 150 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Selected Package
46708-0567-90Selected90 TABLET, FILM COATED in 1 BOTTLE (46708-567-90)
Other packages for this product(1)
30 TABLET, FILM COATED in 1 BOTTLE (46708-567-30)